Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation

Xu, Yan; Zhao, Yanqiu; Doucet, Ludovic; Zhou, Jianying; Wang, Yongsheng; Yang, James Chih-Hsin; FELIP, ENRIQUETA

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Xu, Yan
dc.contributor.author	Zhao, Yanqiu
dc.contributor.author	Doucet, Ludovic
dc.contributor.author	Zhou, Jianying
dc.contributor.author	Wang, Yongsheng
dc.contributor.author	Yang, James Chih-Hsin
dc.contributor.author	FELIP, ENRIQUETA
dc.date.accessioned	2025-06-10T12:30:34Z
dc.date.available	2025-06-10T12:30:34Z
dc.date.issued	2025-05-20
dc.identifier.citation	Xu Y, Yang JCH, Zhao Y, Doucet L, Zhou J, Wang Y, et al. Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation. Cell Reports Med. 2025 May 20;6(5):102121.
dc.identifier.issn	2666-3791
dc.identifier.uri	http://hdl.handle.net/11351/13227
dc.description	Càncer de pulmó de cèl·lules no petites; Biomarcador; Sunvozertinib
dc.language.iso	eng
dc.publisher	Elsevier
dc.relation.ispartofseries	Cell Reports Medicine;6(5)
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	Marcadors tumorals
dc.subject	Pulmons - Càncer - Tractament
dc.subject	Pulmons - Càncer - Aspectes genètics
dc.subject	Proteïnes quinases - Inhibidors - Ús terapèutic
dc.subject.mesh	Carcinoma, Non-Small-Cell Lung
dc.subject.mesh	/drug therapy
dc.subject.mesh	Prognosis
dc.subject.mesh	Protein Kinase Inhibitors
dc.subject.mesh	/therapeutic use
dc.subject.mesh	Biomarkers, Tumor
dc.title	Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1016/j.xcrm.2025.102121
dc.subject.decs	carcinoma de pulmón de células no pequeñas
dc.subject.decs	/farmacoterapia
dc.subject.decs	pronóstico
dc.subject.decs	inhibidores de proteínas cinasas
dc.subject.decs	/uso terapéutico
dc.subject.decs	marcadores tumorales
dc.relation.publishversion	https://doi.org/10.1016/j.xcrm.2025.102121
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Xu Y] Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. [Yang JCH] National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan. [Zhao Y] Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China. [Doucet L] Institut de Cancérologie de l'Ouest (ICO) - René Gauducheau, Saint-Herblain, France. [Zhou J] The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. [Wang Y] West China Hospital, Sichuan University, Chengdu, China. [Felip E] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid	40334661
dc.rights.accessrights	info:eu-repo/semantics/openAccess